Fangning Wan
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 17
- Prostate Cancer Treatment and Research 17
- Ferroptosis and cancer prognosis 14
- Prostate Cancer Diagnosis and Treatment 11
-
- Epigenetics and DNA Methylation 10
- Renal and related cancers 9
- Co-authors
- Dingwei Ye (28 shared papers)Yao Zhu (30 shared papers)Wenhao Xu (14 shared papers)Bo Dai (25 shared papers)Bo Dai (8 shared papers)Hailiang Zhang (17 shared papers)Guohai Shi (22 shared papers)Yunjie Yang (4 shared papers)
- Journals
- Journal of Cancer (5 papers)Frontiers in Oncology (4 papers)Oncotarget (3 papers)Asian Journal of Andrology (3 papers)Tumor Biology (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Fangning Wan
77 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 767
- Pulmonary and Respiratory Medicine 774
- Molecular Biology 1.2k
- Oncology 422
- Immunology and Allergy 41
Countries citing papers authored by Fangning Wan
This map shows the geographic impact of Fangning Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangning Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangning Wan more than expected).
Fields of papers citing papers by Fangning Wan
This network shows the impact of papers produced by Fangning Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangning Wan. The network helps show where Fangning Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangning Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers Hit paper breakdown → | 2019 | 394 |
| 2 | 2019 | 155 | |
| 3 | 2021 | 131 | |
| 4 | 2015 | 78 | |
| 5 | 2018 | 68 | |
| 6 | 2021 | 64 | |
| 7 | 2020 | 61 | |
| 8 | 2020 | 49 | |
| 9 | 2014 | 47 | |
| 10 | 2014 | 46 | |
| 11 | 2015 | 44 | |
| 12 | 2020 | 40 | |
| 13 | 2022 | 38 | |
| 14 | 2022 | 38 | |
| 15 | 2020 | 36 | |
| 16 | 2015 | 35 | |
| 17 | 2018 | 34 | |
| 18 | 2015 | 33 | |
| 19 | 2019 | 32 | |
| 20 | 2015 | 30 |
About Fangning Wan
Fangning Wan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Surgery and Oncology, having authored 78 papers that have together received 2.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (17 papers), Prostate Cancer Treatment and Research (17 papers), Cancer, Lipids, and Metabolism (15 papers), Ferroptosis and cancer prognosis (14 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Epigenetics and DNA Methylation (10 papers), Renal and related cancers (9 papers) and Bladder and Urothelial Cancer Treatments (8 papers). The work is most often cited by research in Cancer Research (767 citations), Pulmonary and Respiratory Medicine (774 citations), Molecular Biology (1.2k citations), Oncology (422 citations) and Immunology and Allergy (41 citations). Fangning Wan has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Dingwei Ye, Yao Zhu, Wenhao Xu, Bo Dai, Bo Dai, Hailiang Zhang, Guohai Shi, Yunjie Yang, Baoquan Ding and Chao Liu. Their work appears in journals such as Journal of Cancer, Frontiers in Oncology, Oncotarget, Asian Journal of Andrology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.